Form 4 · Filed Jun 23, 2026, 10:46 PM UTC
BBIO/BridgeBio Pharma, Inc.
HOMCY CHARLES J — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 20, 2026 | F | other | 788 | $66 | $52,221 | 915,886 |
Source: SEC EDGAR raw filing ↗ · Accession 0001470831-26-000569